Surrogate variables are used as reliable predictors of clinical benefit in various indications. Which option matches this idea?

• A. They are used in marketing applications.
• B. They are used in a number of indications where they are believed to be reliable predictors of clinical benefit.
• C. They must be identical to the primary endpoint.
• D. They replace direct clinical outcomes entirely.

Answer: (B)

Surrogate variables act as stand-ins for the real clinical outcomes, used when there’s evidence that a measurable marker can reliably predict the actual benefit. They let trials use a quicker or easier measure to infer whether patients gain true clinical benefit, and this approach is applied across multiple indications where the surrogate is believed to be predictive. Surrogates are not required to be identical to the primary endpoint, and they do not automatically replace direct clinical outcomes in every situation. They aren’t for marketing purposes, and they aren’t guaranteed to equal the primary outcome. That’s why the best fit is that they’re used in a number of indications where they’re believed to be reliable predictors of clinical benefit.